Overview


3D Drug Eluting Balloons (DEBs) are innovative medical devices used in interventional cardiology and other medical specialties to treat vascular diseases and related conditions. Unlike traditional balloons used for mechanical dilation, DEBs have the added capability of delivering medication directly to the target site within the blood vessel, providing a localized and controlled therapeutic effect. The meaning of 3D Drug Eluting Balloons lies in their unique approach to treating vascular diseases, where they combine mechanical dilation with drug delivery for improved outcomes.

DEBs are coated with a thin layer of medication, typically an anti-proliferative drug, which is released into the surrounding tissue upon balloon inflation. This localized drug delivery helps prevent restenosis, the re-narrowing of the treated blood vessel, which is a common issue after angioplasty or other interventions. By inhibiting excessive tissue growth, DEBs reduce the risk of complications and improve the long-term patency of the treated vessel. These balloons find wide applications in healthcare. One of the primary uses is in the treatment of Coronary Artery Disease (CAD), where plaque buildup narrows the arteries supplying the heart muscle. DEBs are deployed during angioplasty procedures to not only mechanically widen the narrowed vessel but also deliver the anti-proliferative medication to inhibit further tissue growth. Similarly, DEBs are utilized in the treatment of Peripheral Arterial Disease (PAD), restoring blood flow in the legs and non-cardiac areas.

FutureWise Market Research has published a report that provides an insightful analysis of 3D Drug Eluting Balloons Applications in Healthcare Market trends that are affecting the overall market growth. This report will provide a detailed analysis of market share, regional insights, and competitor analysis that includes stature of key manufacturers operational in this industry. By the end of the forecast period FutureWise research analysts projects that 3D Drug Eluting Balloons Applications in Healthcare Market will experience a significant growth. According to the analysis done, this report will help understand the information referring to the total valuation held by this industry. Additionally, this report will help in understanding the growth opportunities held by various segments of this market, further assist in making better strategic and expansion decisions by key stakeholders of an organization.

  • Hewlett Packard
  • Medical Molding inc
  • Proto Labs
  • 3D Systems
  • Stratasys
  • SLM Solutions
  • Nano Dimension
  • ExOne

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Component

  • Devices
  • Materials
  • Services

By Technology

  • Droplet Deposition
    • Fused Deposition Modeling technology
    • Low Temperature Deposition Manufacturing
    • Multiphase Jet Solidification
  • Photo Polymerization
    • Stereo Lithography
    • Continuous Liquid Interface Production
    • Two-photon polymerization
  • Laser Beam Melting
    • Selective Laser Sintering
    • Selective laser Melting
    • Direct Metal Laser Sintering
  • Electronic Beam Melting
  • Laminated Object Manufacturing

By Application

  • External Wearable Devices
  • Clinical Study Devices
  • Implants
  • Tissue Engineering

By End-User

  • Medical and Surgical Centers
  • Pharmaceutical and Biotechnology Companies
  • Academic Institutions

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the 3D Drug Eluting Balloons Applications in Healthcare Market By Component, By Technology, By Application, By End-User and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   3D Drug Eluting Balloons Applications in Healthcare Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of 3D Drug Eluting Balloons Applications in Healthcare Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   3D Drug Eluting Balloons Applications in Healthcare Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   3D Drug Eluting Balloons Applications in Healthcare Market, By Component Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Devices
        2. Materials
        3. Services

  • 8.   3D Drug Eluting Balloons Applications in Healthcare Market, By Technology Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Droplet Deposition
         1.1. Fused Deposition Modeling technology
         1.2. Low Temperature Deposition Manufacturing
         1.3. Multiphase Jet Solidification
        2. Photo Polymerization
         2.1. Stereo Lithography
         2.2. Continuous Liquid Interface Production
         2.3. Two-photon polymerization
        3. Laser Beam Melting
         3.1. Selective Laser Sintering
         3.2. Selective laser Melting
         3.3. Direct Metal Laser Sintering
        4. Electronic Beam Melting
        5. Laminated Object Manufacturing

  • 9.   3D Drug Eluting Balloons Applications in Healthcare Market, By Application Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. External Wearable Devices
        2. Clinical Study Devices
        3. Implants
        4. Tissue Engineering

  • 10.   3D Drug Eluting Balloons Applications in Healthcare Market, By End-User Historical Analysis and Forecast 2024-2032 (USD Million)
    •   1. Medical and Surgical Centers
        2. Pharmaceutical and Biotechnology Companies
        3. Academic Institutions

  • 11.   North America 3D Drug Eluting Balloons Applications in Healthcare Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2024-2032

  • 12.   Latin America 3D Drug Eluting Balloons Applications in Healthcare Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2024-2032

  • 13.   Europe 3D Drug Eluting Balloons Applications in Healthcare Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2024-2032

  • 14.   Asia Pacific 3D Drug Eluting Balloons Applications in Healthcare Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2024-2032

  • 15.   Middle East and Africa Market Analysis 2018-2023 and Forecast 2024-2032 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2018-2023
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2024-2032

  • 16.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 17.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Hewlett Packard
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Medical Molding Inc
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Proto Labs
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. 3D Systems
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Stratasys
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. SLM Solutions
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Nano Dimension.
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. ExOne
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview

  • 18.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the healthcare regulations initiated by
                  administrations
        5. The overall economic slowdown of the developing and developed nations

  • 19.   FutureWise SME Key Takeaway Points for Client

Related Market

Drug Eluting Balloon Market

Read More

Drug Eluting Stents Market

Read More

Implantable Drug Eluting Devices Market

Read More
Partner

Our Clients